Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.073 AUD | 0.00% | -19.78% | +5.80% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+5.80% | 48.82M | |
-6.57% | 3.07B | |
-6.32% | 163M | |
-10.00% | 85.13M | |
-48.00% | 49.3M |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023